Scott Hilderbrand

This inventor holds 1 USPTO granted patent. Top assignee: Axolabs Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Hilderbrand. Retrieved from https://idiyas.com/inventor/scott-hilderbrand-cdukzf5z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scott Hilderbrand: Innovator in Muscle Targeting Complexes

Introduction

Scott Hilderbrand is a notable inventor recognized for his contributions to the field of medical science. He has developed innovative solutions aimed at treating specific muscular disorders. His work is particularly focused on facioscapulohumeral muscular dystrophy, a condition that affects muscle strength and function.

Latest Patents

Scott Hilderbrand holds a patent for "Muscle Targeting Complexes and Formulations for Treating Facioscapulohumeral Muscular Dystrophy." This patent represents a significant advancement in therapeutic approaches for this challenging condition. He has 1 patent to his name, showcasing his commitment to innovation in medical treatments.

Career Highlights

Hilderbrand is currently employed at Axolabs GmbH, where he continues to push the boundaries of research and development in the medical field. His role at the company allows him to collaborate with other experts and contribute to groundbreaking projects.

Collaborations

Throughout his career, Scott has worked alongside talented individuals such as Timothy Weeden and Nelson Hsia. These collaborations have enriched his research and have led to the development of impactful medical solutions.

Conclusion

Scott Hilderbrand is a dedicated inventor whose work in muscle targeting complexes is making a difference in the treatment of muscular dystrophy. His innovative spirit and collaborative efforts continue to drive advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…